Atrium Therapeutics, Inc. (RNA)

NASDAQ: RNA · Real-Time Price · USD

12.84

+0.51 (4.14%)

At close: Aug 14, 2026, 4:00 PM EDT

12.87

+0.03 (0.19%)

After-hours: Aug 14, 2026, 7:34 PM EDT

Atrium Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accounts Receivable	-	-	-	0.75
Other Receivables	-	0.1	-	-
Receivables	-	0.1	-	0.75
Prepaid Expenses	4.51	1.54	0.48	0.11
Other Current Assets	6.33	1.21	-	-
Total Current Assets	275.05	2.85	0.48	0.86
Property, Plant & Equipment	5.36	5.51	6.7	9.44
Total Assets	280.51	8.35	7.19	10.29
Accounts Payable	3.51	4.4	0.53	0.5
Accrued Expenses	17.27	8.69	1.44	1.5
Current Portion of Leases	1.68	3.67	3.84	3.64
Current Unearned Revenue	9.04	21.64	20.99	28.16
Other Current Liabilities	-	3.4	-	-
Total Current Liabilities	31.51	41.8	26.8	33.8
Long-Term Leases	-	-	2.96	6.21
Long-Term Unearned Revenue	33.65	28.69	37.96	40.9
Other Long-Term Liabilities	0.78	0.57	0.57	-
Total Liabilities	65.94	71.07	68.29	80.91
Common Stock	0.02	-62.71	-61.11	-70.62
Shareholders' Equity	214.58	-62.71	-61.11	-70.62
Total Liabilities & Equity	280.51	8.35	7.19	10.29
Total Debt	1.68	3.67	6.8	9.85
Net Cash (Debt)	262.22	-3.67	-6.8	-9.85
Net Cash Growth	-	-	-	-
Net Cash Per Share	15.33	-0.24	-	-
Filing Date Shares Outstanding	17.11	15.51	-	-
Total Common Shares Outstanding	17.11	15.51	-	-
Working Capital	243.54	-38.96	-26.32	-32.95
Book Value Per Share	12.54	-4.04	-	-
Tangible Book Value	214.58	-62.71	-61.11	-70.62
Tangible Book Value Per Share	12.54	-4.04	-	-
Machinery	-	5.57	2.03	1.76
Leasehold Improvements	-	-	0.29	0.29